Federated Hermes, Inc. Bellerophon Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

  • $41.2 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.85 - $2.36 $130 - $361
-153 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$1.82 - $3.24 $20 - $35
-11 Reduced 6.71%
153 $1,000
Q4 2021

Feb 14, 2022
BUY
$2.36 - $4.05 $387 - $664
164 New
164 $1,000

Others Institutions Holding BLPH

# of Institutions
1
Shares Held
44K
Call Options Held
0
Put Options Held
0
View Full List

About Bellerophon Therapeutics, Inc.

BLPH Quotes by TradingView
  • Ticker BLPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,545,450
  • Market Cap $382K
  • Description
  • Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...
More about BLPH
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email